unknown
Meloxoral 1.5mg / ml Oral Suspension for Dogs 10ml

Meloxoral 1.5mg / ml Oral Suspension for Dogs 10ml

Relief of inflammation and pain in acute and chronic musculoskeletal disorders in dogs.

7454942
€17.90
Tax included
Medicinal product subject to veterinary prescription. (988 Items)
Medicinal product subject to veterinary prescription. (988 Items)
✓ Medicinal product subject to veterinary prescription.
Add to wishlist Added to wishlist
 Calculate Shipping Cost

Relief of inflammation and pain in acute and chronic musculoskeletal disorders in dogs.

Active substance: Meloxicam

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam group, which acts by inhibiting the synthesis of prostaglandins, thereby exercising anti-inflammatory, analgesic, anti-exudative and antipyretic effects. Reduces leukocyte infiltration into inflamed tissue. To a lesser extent, it also inhibits thrombocyte aggregation induced by collagen. In vitro and in vivo studies have shown that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).

Posology and route of administration:

Oral use. Administer mixed with food or directly in the mouth. Shake well before use.

The initial treatment is a single dose of 0.2 mg meloxicam / kg body weight on the first day. Treatment should continue with oral administration once daily (at 24-hour intervals), at a maintenance dose of 0.1 mg meloxicam / kg body weight.

For more prolonged treatment, and once the clinical response is observed (after ≥ 4 days), the dose of the veterinary medicinal product can be adjusted to the lowest effective individual dose, reflecting that the degree of pain and inflammation associated with muscle diseases. Chronic skeletal disorders may vary over time.

The clinical response is usually seen within 3 - 4 days. Treatment should be stopped after a maximum of 10 days, if no clinical improvement is apparent.

Because it is a veterinary medicinal product subject to medical prescription, we request to send it to the email: [email protected]

Top